Require Prescription
Description:
Jakavi is a medication primarily used for the treatment of certain types of myelofibrosis and polycythemia vera. It works by targeting specific enzymes involved in the growth and survival of cancer cells and abnormal blood cells.
Ingredients:
Each tablet contains 15 mg of ruxolitinib (as ruxolitinib phosphate).
Usage Instructions:
Typically, Jakavi is taken orally, usually with food. The recommended starting dose varies depending on the condition being treated and the patient's medical history. Dosage adjustments may be necessary based on individual response and tolerability. It's important to follow your doctor's instructions carefully.
Benefits:
-
- Treatment of myelofibrosis and polycythemia vera.
- Reduction in spleen size and related symptoms.
- Improvement in overall quality of life for patients with these conditions.
Precautions:
-
- Jakavi may cause serious side effects such as infections, anemia, and thrombocytopenia.
- Patients should be monitored regularly for blood counts and liver function.
- Avoid use in patients with severe hepatic impairment.
Storage Instructions:
- Store Jakavi at room temperature between 20-25°C (68-77°F). Protect from light and moisture. Keep out of reach of children
Manufacturer:
Novartis Pharmaceuticals.
